64 related articles for article (PubMed ID: 8267380)
1. p53 mutations in colorectal cancers in the patients of Metropolitan New York.
van den Broek MH; Jhanwar SC; Fodde R; Chaganti RS; Meera Khan PM
Anticancer Res; 1993; 13(5C):1769-72. PubMed ID: 8267380
[TBL] [Abstract][Full Text] [Related]
2. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands.
Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM
Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886
[TBL] [Abstract][Full Text] [Related]
3. Discordance of p53 mutations of synchronous colorectal carcinomas.
Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
[TBL] [Abstract][Full Text] [Related]
4. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
6. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
[TBL] [Abstract][Full Text] [Related]
7. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.
Hartmann A; Blaszyk H; McGovern RM; Schroeder JJ; Cunningham J; De Vries EM; Kovach JS; Sommer SS
Oncogene; 1995 Feb; 10(4):681-8. PubMed ID: 7862445
[TBL] [Abstract][Full Text] [Related]
10. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
12. [p53 gene point mutation in human colorectal carcinoma].
Xu W; Yang D; Wan Y
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):328-31. PubMed ID: 8697967
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
14. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
15. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
16. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors.
Hamelin R; Jego N; Laurent-Puig P; Vidaud M; Thomas G
Oncogene; 1993 Aug; 8(8):2213-20. PubMed ID: 8336944
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
20. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
